Safer Tripping

Total Page:16

File Type:pdf, Size:1020Kb

Safer Tripping If you’re having a Getting Help bad trip… Self-help tools: Go to a safe environment (if you’re not already www.heretohelp.bc.ca in one) and play calming music. www.carbc.ca Surrender to the experience (rather than trying Saf er to control it). Alcohol and Drug Information and Try to meditate or relax. Referral Service: Tripping The only way to guarantee you won’t have a bad 1-800-663-1441 (BC) trip is to not use hallucinogens. magic mushrooms, LSD, 604-660-9382 (Greater Vancouver) and other hallucinogens If someone else is having a bad trip… Take them to a calm, safe environment. Reassure them that you’re their friend and that in time the experience will pass. Help them meditate or relax. Reduce your risk of bad trips (scary and stressful experiences), injuries from falls or accidents, and mental health problems © 2012 Here to Help Here to Help is a project of the BC Partners for Mental Health and Addictions Information. This brochure was developed by the Centre for Addictions Research of BC, a member of the BC Partners. When you’re tripping... Think about NOT using You and safer Be sure you’re in the right frame of hallucinogens if... Using hallucinogens can be fun, spiritual or mind you or a family member have a history educational if you embrace the experience. It can tripping of mental health problems Hallucinating also be scary, especially if you try to control rather Using hallucinogens is always risky can trigger symptoms of a mental health than “roll with it.” because they are illegal drugs. You can problem. never know for sure what you’re buying or Avoid bad experiences Steer clear of climbing you’re living with a heart condition using. There are other risks too. Some are up on things, looking in the mirror, or having sex Many hallucinogens affect blood pressure and related to how hallucinogens affect your with anyone other than a comfortable, familiar heart rate. partner. These activities can have unpleasant or mind and body. Others are related to your you’re experiencing symptoms of unexpected results. relationships with people. Here are some a mental health problem This includes ways you can reduce those risks. Stick to one substance at a time Using depression or anxiety. Hallucinogens may cannabis and alcohol while tripping can change your interact with mental health medications. experience in unpredictable ways. you can’t keep yourself or others safe Before you start... while using hallucinogens Safety needs Think about why you want to get high to be a main priority. It’s best not to use hallucinogens as a way of you’re using hallucinogens too often avoiding or coping with problems. It’s best not to use drugs as your main way of Know your dealer It’s best to choose someone having fun or handling boredom, unhappiness you feel safe with and who knows about the drugs or stress in your life. they sell. you’re concerned about people finding Find a buddy (who won’t be tripping) Using out about your use of hallucinogens alone can mean coping by yourself if you get injured Having and maintaining good relationships with or have a bad trip. your family and friends is more important. Stay away from the steering wheel Your Plan your trip Choose a safe, peaceful place to judgment and coordination may be greatly impaired. hang out, knowing that most trips last 8-12 hours. Talk to your friend about things you could do if you have a bad trip..
Recommended publications
  • The Ethics of Psychedelic Medicine: a Case for the Reclassification of Psilocybin for Therapeutic Purposes
    THE ETHICS OF PSYCHEDELIC MEDICINE: A CASE FOR THE RECLASSIFICATION OF PSILOCYBIN FOR THERAPEUTIC PURPOSES By Akansh Hans A thesis submitted to Johns Hopkins University in conformity with the requirements for the degree of Master of Bioethics Baltimore, Maryland May 2021 © 2021 Akansh Hans All Rights Reserved I. Abstract Our current therapeutic mental health paradigms have been unable to adequately handle the mental illness crisis we are facing. We ought to ‘use every tool in our toolbox’ to help individuals heal, and the tool we should be utilizing right now is Psilocybin. Although it is classified as a Schedule I drug, meaning that it is believed to have a high potential for abuse, no accepted medical uses, and a lack of safety when used under medical supervision, Psilocybin is not addictive and does not have a high potential for abuse when used safely under medical supervision. For these reasons alone, Psilocybin deserves a reclassification for therapeutic purposes. However, many individuals oppose Psilocybin-assisted psychotherapy on ethical grounds or due to societal concerns. These concerns include: a potential change in personal identity, a potential loss of human autonomy, issues of informed consent, safety, implications of potential increased recreational use, and distributive justice and fairness issues. Decriminalization, which is distinct from reclassification, means that individuals should not be incarcerated for the use of such plant medicines. This must happen first to stop racial and societal injustices from continuing as there are no inherently ‘good’ or ‘bad’ drugs. Rather, these substances are simply chemicals that humans have developed relationships with. As is shown in this thesis, the ethical implications and risks of psychedelic medicine can be adequately addressed and balanced, and the benefits of Psilocybin as a healing tool far outweigh the risks.
    [Show full text]
  • Hallucinogens
    Hallucinogens What Are Hallucinogens? Hallucinogens are a diverse group of drugs that alter a person’s awareness of their surroundings as well as their thoughts and feelings. They are commonly split into two categories: classic hallucinogens (such as LSD) and dissociative drugs (such as PCP). Both types of hallucinogens can cause hallucinations, or sensations and images that seem real though they are not. Additionally, dissociative drugs can cause users to feel out of control or disconnected from their body and environment. Some hallucinogens are extracted from plants or mushrooms, and others are synthetic (human-made). Historically, people have used hallucinogens for religious or healing rituals. More recently, people report using these drugs for social or recreational purposes. Hallucinogens are a Types of Hallucinogens diverse group of drugs Classic Hallucinogens that alter perception, LSD (D-lysergic acid diethylamide) is one of the most powerful mind- thoughts, and feelings. altering chemicals. It is a clear or white odorless material made from lysergic acid, which is found in a fungus that grows on rye and other Hallucinogens are split grains. into two categories: Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) comes from certain classic hallucinogens and types of mushrooms found in tropical and subtropical regions of South dissociative drugs. America, Mexico, and the United States. Peyote (mescaline) is a small, spineless cactus with mescaline as its main People use hallucinogens ingredient. Peyote can also be synthetic. in a wide variety of ways DMT (N,N-dimethyltryptamine) is a powerful chemical found naturally in some Amazonian plants. People can also make DMT in a lab.
    [Show full text]
  • Adverse Reactions to Hallucinogenic Drugs. 1Rnstttutton National Test
    DOCUMENT RESUME ED 034 696 SE 007 743 AUTROP Meyer, Roger E. , Fd. TITLE Adverse Reactions to Hallucinogenic Drugs. 1rNSTTTUTTON National Test. of Mental Health (DHEW), Bethesda, Md. PUB DATP Sep 67 NOTE 118p.; Conference held at the National Institute of Mental Health, Chevy Chase, Maryland, September 29, 1967 AVATLABLE FROM Superintendent of Documents, Government Printing Office, Washington, D. C. 20402 ($1.25). FDPS PRICE FDPS Price MFc0.50 HC Not Available from EDRS. DESCPTPTOPS Conference Reports, *Drug Abuse, Health Education, *Lysergic Acid Diethylamide, *Medical Research, *Mental Health IDENTIFIEPS Hallucinogenic Drugs ABSTPACT This reports a conference of psychologists, psychiatrists, geneticists and others concerned with the biological and psychological effects of lysergic acid diethylamide and other hallucinogenic drugs. Clinical data are presented on adverse drug reactions. The difficulty of determining the causes of adverse reactions is discussed, as are different methods of therapy. Data are also presented on the psychological and physiolcgical effects of L.S.D. given as a treatment under controlled medical conditions. Possible genetic effects of L.S.D. and other drugs are discussed on the basis of data from laboratory animals and humans. Also discussed are needs for futher research. The necessity to aviod scare techniques in disseminating information about drugs is emphasized. An aprentlix includes seven background papers reprinted from professional journals, and a bibliography of current articles on the possible genetic effects of drugs. (EB) National Clearinghouse for Mental Health Information VA-w. Alb alb !bAm I.S. MOMS Of NAM MON tMAN IONE Of NMI 105 NUNN NU IN WINES UAWAS RCM NIN 01 NUN N ONMININI 01011110 0.
    [Show full text]
  • DEMAND REDUCTION a Glossary of Terms
    UNITED NATIONS PUBLICATION Sales No. E.00.XI.9 ISBN: 92-1-148129-5 ACKNOWLEDGEMENTS This document was prepared by the: United Nations International Drug Control Programme (UNDCP), Vienna, Austria, in consultation with the Commonwealth of Health and Aged Care, Australia, and the informal international reference group. ii Contents Page Foreword . xi Demand reduction: A glossary of terms . 1 Abstinence . 1 Abuse . 1 Abuse liability . 2 Action research . 2 Addiction, addict . 2 Administration (method of) . 3 Adverse drug reaction . 4 Advice services . 4 Advocacy . 4 Agonist . 4 AIDS . 5 Al-Anon . 5 Alcohol . 5 Alcoholics Anonymous (AA) . 6 Alternatives to drug use . 6 Amfetamine . 6 Amotivational syndrome . 6 Amphetamine . 6 Amyl nitrate . 8 Analgesic . 8 iii Page Antagonist . 8 Anti-anxiety drug . 8 Antidepressant . 8 Backloading . 9 Bad trip . 9 Barbiturate . 9 Benzodiazepine . 10 Blood-borne virus . 10 Brief intervention . 11 Buprenorphine . 11 Caffeine . 12 Cannabis . 12 Chasing . 13 Cocaine . 13 Coca leaves . 14 Coca paste . 14 Cold turkey . 14 Community empowerment . 15 Co-morbidity . 15 Comprehensive Multidisciplinary Outline of Future Activities in Drug Abuse Control (CMO) . 15 Controlled substance . 15 Counselling and psychotherapy . 16 Court diversion . 16 Crash . 16 Cross-dependence . 17 Cross-tolerance . 17 Custody diversion . 17 Dance drug . 18 Decriminalization or depenalization . 18 Demand . 18 iv Page Demand reduction . 19 Dependence, dependence syndrome . 19 Dependence liability . 20 Depressant . 20 Designer drug . 20 Detoxification . 20 Diacetylmorphine/Diamorphine . 21 Diuretic . 21 Drug . 21 Drug abuse . 22 Drug abuse-related harm . 22 Drug abuse-related problem . 22 Drug policy . 23 Drug seeking . 23 Drug substitution . 23 Drug testing . 24 Drug use .
    [Show full text]
  • Hallucinogens
    Hallucinogens What are hallucinogens? Hallucinogens are a diverse group of drugs that alter a person’s awareness of their surroundings as well as their own thoughts and feelings. They are commonly split into two categories: classic hallucinogens (such as LSD) and dissociative drugs (such as PCP). Both types of hallucinogens can cause hallucinations, or sensations and images that seem real though they are not. Additionally, dissociative drugs can cause users to feel out of control or disconnected from their body and environment. Some hallucinogens are extracted from plants or mushrooms, and some are synthetic (human- made). Historically, people have used hallucinogens for religious or healing rituals. More recently, people report using these drugs for social or recreational purposes, including to have fun, deal with stress, have spiritual experiences, or just to feel different. Common classic hallucinogens include the following: • LSD (D-lysergic acid diethylamide) is one of the most powerful mind-altering chemicals. It is a clear or white odorless material made from lysergic acid, which is found in a fungus that grows on rye and other grains. LSD has many other street names, including acid, blotter acid, dots, and mellow yellow. • Psilocybin (4-phosphoryloxy-N,N- dimethyltryptamine) comes from certain types of mushrooms found in tropical and subtropical regions of South America, Mexico, and the United States. Some common names for Blotter sheet of LSD-soaked paper squares that users psilocybin include little smoke, magic put in their mouths. mushrooms, and shrooms. Photo by © DEA • Peyote (mescaline) is a small, spineless cactus with mescaline as its main ingredient. Peyote can also be synthetic.
    [Show full text]
  • Hallucinogens Hallucinations
    Hallucinogens Hallucinations Affect a person’s: Perceptions Sensations Thinking Self-awareness Emotional state Synesthesia Transposition of senses: Seeing sounds Hearing colors Flash Back Vivid recollection of hallucinogenic experience Emotional “Bad trip” (Panic, fear, etc.) Somatic Altered body sensations, tremors, weakness, dizziness, crawly, tingling feeling on the skin Perceptual Distortions of the five senses Psychotomimetic Something that mimics psychosis Delusion A false belief Illusion A false perception Natural Hallucinogens Peyote (Mescaline) Psilocybin Natural Hallucinogens Jimson Weed Bufo Alvarius Natural Hallucinogens Morning Glory Seeds Nutmeg Natural Hallucinogens Salvia Divinorum Synthetic Hallucinogens LSD (Lysergic Acid Diethylamide) MDMA “Ecstasy” (3, 4 Methylenedioxymethamphetamine) Methods of Ingestion Orally Smoked Transdermal Insufflation Injection General Indicators Varies and influenced by personality, mood, expectations and surroundings of user Depressed = deeper depression Pleasant = heightened pleasure Can uncover emotional flaws Bad “trip” Effects Hallucinations Body tremors Paranoia Uncoordinated Nausea Disoriented Perspiring Memory loss Difficulty in speech Flashbacks Synesthesia Poor time perception Dazed appearance Onset and Duration - Peyote 30 minutes: Onset Nausea, elevated blood pressure, pulse and temperature and dilated pupils 60 minutes: Begin hallucinogenic effects Visual distortions, rich colors, changing forms and moving shapes 3-4 hours: Peak effects “Synesthesia”
    [Show full text]
  • Technology for Drug Testing
    If you have issues viewing or accessing this file, please contact us at NCJRS.gov. Aud,OTeleconlerence Packet Technology for Drug Testing November 17, 1998 2:30 - 4:00 p.m. (EST) F'ROr:'t::~"~ ~ '~ ,.jr: National Criminal Justice Releronce Service (~NOJ.R..~).,, ,~..~ ... Box 6000 .... "-- Rockville, ME) 20849 °6000i'~~ ............ Kevin Jackson Saralyn Borrowman Presenters Provided by the American Probation and Parole Association Funded by the Office of Juvenile Justice and Delinquency Prevention © ® Prepared under Award No. 98-JB-VX-0103 from the Office of Juvenile Justice and Delinquency Prevention, Office of Justice Programs, U. S. Department of Justice. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the U. S. Department of Justice. © TECHNOLOGY FOR DRUG TESTING Training Objectives As a result of this teleconference, participants will be able to: • Name six types of technology for substance abuse testing and describe the relative advantages and disadvantages of each. • Describe the difference between immunoassay and chromatography testing for urine. • List the classifications of substances that can be detected through urine testing and those for which tests are either unavailable or require more difficult or costly testing methods. • Identify ways that urine tests can be adulterated or otherwise tampered with and ways to detect and/or avoid these problems. • Make decisions for program policies and procedures regarding onsite or off site testing, instrument or noninstrument testing, drugs to test for, scheduled or random testing, frequency of testing, specimen collection procedures, chain of custody procedures, confirmation tests, cutoff levels; and • Specify how positive and negative results will be used ABOUT THE PRESENTERS Kevin Jackson Saralyn Borrowman National Institute of Justice Office of Science and Technology Washington, D.C.
    [Show full text]
  • DRE IG 14 01 Session.Pdf
    Session 14 - Hallucinogens Session 14 - Hallucinogens Learning Objectives Learning Objectives • Explain a brief history of the • Describe the typical time parameters, Hallucinogen category of drugs i.e. onset and duration of effects • Identify common drug names and associated with this category terms associated with this category • List the clues that are likely to emerge • Identify common methods of when the drug influence evaluation is administration for this category conducted for a person under the • Describe the symptoms, observable influence of this category of drugs signs and other effects associated with • Correctly answer the “topics for study” this category questions at the end of this session Drug Recognition Expert Course 14-2 Drug Recognition Expert Course 14-3 Briefly review the objectives, content and activities of this session. Upon successfully completing this session the participant will be able to: • Explain a brief history of the Hallucinogen category of drugs • Identify common drug names and terms associated with this category • Identify common methods of administration for this category • Describe the symptoms, observable signs and other effects associated with this category • Describe typical time parameters, i.e. onset and duration of effects, associated with this category • List the clues that are likely to emerge when the drug influence evaluation is conducted for a person under the influence of this category of drugs • Correctly answer the “topics for study” questions at the end of this session CONTENT SEGMENTS
    [Show full text]
  • Mental Health Effects of Recreational Drugs and Alcohol Understanding
    Understanding the mental health effects of recreational drugs and alcohol understanding mental health effects of recreational drugs and alcohol 1 Understanding the mental health effects of recreational drugs and alcohol This booklet is for anyone who wants to know more about the mental health effects of recreational drugs and alcohol. It explains how drugs and alcohol affect mental health, and what might happen if you use recreational drugs and have a mental health problem. It also provides information on what support is available and guidance for friends and family. Contents What are recreational drugs and alcohol? 4 How can recreational drugs affect mental health? 5 What types of drugs are there? 8 What effect could different drugs have? 11 Can recreational drugs and medication affect each other? 32 What support is available? 36 What help is available if I have a dual diagnosis? 38 How can family and friends help? 42 Useful contacts 45 3 Understanding the mental health effects of recreational drugs and alcohol What are recreational drugs and alcohol? Drugs are substances people take: • to give themselves a pleasurable experience • to help them feel better if they are having a bad time • because their friends are using them • to see what it feels like. They include alcohol, tobacco (nicotine), substances such as cannabis, heroin, cocaine and ecstasy, and some prescribed medicines. All my experiences with recreational drug use started due to social influences, of wanting to 'fit in'. Recreational drugs may be: • legal – such as nicotine and alcohol • illegal – this means it is against the law to have them or supply them to other people; most recreational drugs are illegal • controlled – these are drugs used in medicine, such as benzodiazepines; it is legal to take controlled drugs if a doctor has given you a prescription for them but it is illegal to have them if not; it is also illegal to give or sell controlled drugs to anyone else.
    [Show full text]
  • Downloaded 09/26/21 04:47 PM UTC Ona What, If Any, Extra-Pharmacological Factors Are Commonly SECTION 1 Related to the Adverse Reaction Known As a Bad Trip
    ORIGINAL ARTICLE Journal of Psychedelic Studies 2(1), pp. 53–60 (2018) DOI: 10.1556/2054.2018.001 First published online March 20, 2018 Inside bad trips: Exploring extra-pharmacological factors GENÍS ONA* Department of Anthropology, Rovira i Virgili University, Tarragona, Spain (Received: June 18, 2017; revised manuscript received: January 16, 2018; accepted: January 17, 2018) Objective: This study aimed to clarify the influence of extra-pharmacological factors in the etiology of bad trips,a common adverse reaction related to the consumption of psychedelic drugs. Methods: A descriptive approach was adopted. The information was collected using a web-based survey. The survey respondents volunteered to participate based on the condition that they had suffered a bad trip in the past. Results: This report reveals some variables that are commonly related to this adverse reaction (i.e., the recreational consumption of drugs, the consumption of drugs in large, open outdoor spaces, or being inexperienced with the drug). In addition, we note that some problems, which may be related to bad trips (i.e., mixing drugs, ignorance about the purity, or the dosage), can be solved through harm- reduction strategies. Conclusions: We found certain aspects that could be related to the appearance of a bad trip, but it is not possible to establish a causal connection. We recommend conducting prospective studies with larger samples to collect more information about the role of extra-pharmacological factors. Keywords: psychedelic, bad trip, drug, adverse reaction
    [Show full text]
  • Nbomes–Highly Potent and Toxic Alternatives of LSD
    fnins-14-00078 February 24, 2020 Time: 17:4 # 1 REVIEW published: 26 February 2020 doi: 10.3389/fnins.2020.00078 NBOMes–Highly Potent and Toxic Alternatives of LSD Jolanta B. Zawilska1*, Monika Kacela1 and Piotr Adamowicz2 1 Department of Pharmacodynamics, Medical University of Łód´z,Łód´z,Poland, 2 Department of Forensic Toxicology, Institute of Forensic Research, Kraków, Poland Recently, a new class of psychedelic compounds named NBOMe (or 25X-NBOMe) has appeared on the illegal drug market. NBOMes are analogs of the 2C family of phenethylamine drugs, originally synthesized by Alexander Shulgin, that contain a N-(2-methoxy)benzyl substituent. The most frequently reported drugs from this group are 25I-NBOMe, 25B-NBOMe, and 25C-NBOMe. NBOMe compounds are ultrapotent and highly efficacious agonists of serotonin 5-HT2A and 5-HT2C receptors (Ki values in low nanomolar range) with more than 1000-fold selectivity for 5-HT2A compared with 5-HT1A. They display higher affinity for 5-HT2A receptors than their 2C counterparts and have markedly lower affinity, potency, and efficacy at the 5- HT2B receptor compared to 5-HT2A or 5-HT2C. The drugs are sold as blotter papers, or in powder, liquid, or tablet form, and they are administered sublingually/buccally, intravenously, via nasal insufflations, or by smoking. Since their introduction in the early 2010s, numerous reports have been published on clinical intoxications and Edited by: Liana Fattore, fatalities resulting from the consumption of NBOMe compounds. Commonly observed Italian National Research Council, Italy adverse effects include visual and auditory hallucinations, confusion, anxiety, panic Reviewed by: and fear, agitation, uncontrollable violent behavior, seizures, excited delirium, and Adam Halberstadt, sympathomimetic signs such mydriasis, tachycardia, hypertension, hyperthermia, and University of California, San Diego, United States diaphoresis.
    [Show full text]
  • Health Risks Associated with the Use of Illicit Drugs and Alcohol
    HEALTH RISKS ASSOCIATED WITH THE USE OF ILLICIT DRUGS AND ALCOHOL The brief summaries are an overview of the major health risks associated with the use of illicit drugs and alcohol. Abuse of alcohol and other drugs can lead to chemical dependency and can be harmful during pregnancy. Alcohol—Did you know that • Alcohol is a depressant that decreases the responses of the central nervous system. • Excessive drinking can cause liver damage and psychotic behavior. • As little as two beers or drinks can impair coordination and thinking. • Alcohol is often used by substance abusers to enhance the effects of other drugs. • Alcohol continues to be the most frequently abused substance among young adults. What are the Dangers of Alcohol Abuse? Risk of injury or death as a result of accident or violence, impaired vision, impaired motor coordination, memory defects, hallucinations, blackouts, and seizures. Long-term use can result in permanent damage to the brain, elevated blood pressure and heart rate, risk of stroke, heart failure, respiratory depression and failure, pneumonia, tuberculosis, lung abscesses, increased risk of mouth and throat cancer, alcoholic fatty liver, hepatitis, and cirrhosis, duodenal ulcers, reflux, diarrhea, impaired judgment and verbal ability, apathy, introversion, antisocial behavior, inability to concentrate, and deterioration of relationships with family, friends, and co-workers. Alcohol is an especially dangerous drug for pregnant women. Drinking during pregnancy raises the risk of low-birth weight babies and intrauterine growth retardation, increasing the danger of infection, feeding difficulties, and long-term developmental problems. Marijuana—Also known as: Pot, Grass, Joints, Roaches, Reefer, Weed, Mary Jane—Did you know that • Marijuana may cause impaired short-term memory, a shortened attention span and delayed reflexes.
    [Show full text]